Estados financieros detallados de American Shared Hospital Services (AMS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
American Shared Hospital Services registró ingresos de $28.1M en el último ejercicio fiscal, con un CAGR de 5 años del 9.5%.
Márgenes de los últimos 12 meses: margen bruto 17.1%, margen operativo -8.4%, margen neto -5.8%.
Al precio actual de $1.42, AMS presenta beneficios negativos (P/E no significativo) y un ROE del -7.45%. La capitalización bursátil es de $9M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $18.7M | $19.6M | $19.7M | $20.6M | $17.8M | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M |
| Coste de Ventas | $9.9M | $10.9M | $12.2M | $13.7M | $13.4M | $10.9M | $11.4M | $12.0M | $19.2M | $23.0M |
| Beneficio Bruto | $8.8M | $8.7M | $7.5M | $6.9M | $4.5M | $6.7M | $8.4M | $9.3M | $9.2M | $5.0M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $3.8M | $4.3M | $4.0M | $4.1M | $4.6M | $4.5M | $5.1M | $7.0M | $7.4M | $7.1M |
| Gastos Operativos | $3.8M | $4.3M | $4.0M | $4.1M | $13.9M | $5.4M | $6.0M | $9.1M | $12.0M | $7.1M |
| Beneficio Operativo | $3.3M | $2.4M | $1.9M | -$4.5M | -$9.5M | $1.4M | $2.4M | $270000 | -$2.8M | -$2.0M |
| EBITDA | $11.3M | $11.0M | $10.3M | $10.3M | -$1.4M | $7.0M | $8.4M | $7.0M | $8.9M | $4.1M |
| Gastos por Intereses | $1.7M | $1.9M | $1.6M | $1.3M | $1.1M | $742000 | $806000 | $1.1M | $1.5M | $1.6M |
| Beneficio Antes de Impuestos | $3.2M | $1.8M | $2.1M | $1.6M | -$9.5M | $947000 | $2.5M | $696000 | $1.2M | -$3.2M |
| Impuestos | $943000 | -$1.1M | $451000 | $128000 | -$1.7M | $269000 | $963000 | $431000 | -$295000 | -$493000 |
| Beneficio Neto | $930000 | $1.9M | $1.0M | $659000 | -$7.1M | $194000 | $1.3M | $610000 | $2.2M | -$1.6M |
| BPA | $0.17 | $0.33 | $0.18 | $0.24 | $-1.14 | $0.03 | $0.21 | $0.10 | $0.34 | $-0.23 |
| BPA Diluido | $0.17 | $0.33 | $0.17 | $0.24 | $-1.14 | $0.03 | $0.21 | $0.10 | $0.33 | $-0.23 |
| Acciones en Circulación (Diluidas) | $5.5M | $5.8M | $6.0M | $5.9M | $6.2M | $6.1M | $6.3M | $6.4M | $6.7M | $6.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $7.2M | $7.7M | $7.1M | $8.4M |
| Beneficio Bruto | $1.6M | $906000 | $1.3M | $1.4M |
| Beneficio Operativo | $48000 | -$1.1M | -$622000 | -$910000 |
| EBITDA | $1.6M | $419000 | $726000 | $384000 |
| Beneficio Neto | -$17000 | -$631000 | -$612000 | -$514000 |
| BPA | $-0.00 | $-0.09 | $-0.09 | $-0.07 |
| BPA Diluido | $-0.00 | $-0.09 | $-0.09 | $-0.07 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $2.9M | $2.2M | $1.4M | $1.4M | $4.0M | $8.1M | $12.3M | $13.7M | $11.0M | $3.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $4.4M | $5.2M | $6.9M | $7.1M | $4.6M | $4.8M | $4.1M | $4.8M | $12.7M | $13.2M |
| Inventario | $250000 | $350000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.4M | $8.9M | $9.9M | $10.7M | $10.8M | $15.1M | $18.7M | $20.5M | $26.3M | $17.7M |
| Inmovilizado Material | $51.3M | $48.5M | $46.7M | $42.6M | $31.3M | $28.9M | $23.8M | $25.9M | $32.2M | $36.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
| Activos Intangibles | 0 | 0 | 0 | 0 | $78000 | $78000 | $78000 | $78000 | $78000 | $78000 |
| Activos Totales | $60.6M | $58.2M | $57.5M | $53.8M | $43.7M | $45.4M | $44.0M | $48.2M | $60.2M | $55.5M |
| Cuentas por Pagar | $319000 | $359000 | $435000 | $557000 | $683000 | $318000 | $230000 | $315000 | $1.6M | $607000 |
| Deuda a Corto | $2.2M | $2.5M | $2.1M | $1.5M | $1.2M | $2.4M | $1.8M | $6.5M | $4.2M | $18.2M |
| Pasivos Corrientes | $8.7M | $9.0M | $9.5M | $8.2M | $12.4M | $5.9M | $5.2M | $10.8M | $10.4M | $23.4M |
| Deuda a Largo | $5.1M | $3.6M | $3.3M | $2.0M | $3.4M | $14.3M | $12.2M | $11.0M | $17.3M | 0 |
| Pasivos Totales | $33.4M | $28.3M | $26.5M | $22.0M | $20.0M | $21.2M | $18.3M | $21.9M | $30.2M | $27.8M |
| Reservas | $5.0M | $6.9M | $7.9M | $8.6M | $1.5M | $1.7M | $3.0M | $3.6M | $5.8M | $4.3M |
| Patrimonio Neto | $27.2M | $29.9M | $31.0M | $31.8M | $19.3M | $19.9M | $21.6M | $22.6M | $25.2M | $24.0M |
| Deuda Total | $27.0M | $23.1M | $20.2M | $16.5M | $14.4M | $17.5M | $14.3M | $17.6M | $23.2M | $22.6M |
| Deuda Neta | $24.2M | $21.0M | $18.7M | $15.0M | $10.4M | $9.3M | $2.0M | $4.0M | $12.2M | $19.1M |
| Capital Circulante | -$293000 | -$114000 | $472000 | $2.5M | -$1.5M | $9.2M | $13.5M | $9.7M | $15.9M | -$5.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.3M | $3.5M | $5.2M | $6.5M |
| Activos Totales | $59.6M | $55.5M | $54.7M | $52.5M |
| Pasivos Totales | $31.0M | $27.8M | $28.0M | $26.7M |
| Patrimonio Neto | $24.6M | $24.0M | $23.5M | $23.1M |
| Deuda Total | $24.6M | $22.6M | $21.2M | $20.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | $2.2M | $2.9M | $1.6M | $1.4M | -$7.7M | $194000 | $1.6M | $265000 | $1.5M | -$2.7M |
| Amortizaciones | $6.3M | $6.7M | $6.8M | $7.4M | $7.0M | $5.3M | $4.8M | $5.2M | $6.2M | $5.7M |
| Compensación en Acciones | $215000 | $323000 | $223000 | $230000 | $299000 | 0 | $399000 | $389000 | $373000 | $404000 |
| Cambio en Capital Circulante | -$1.7M | -$1.5M | -$696000 | -$941000 | $3.8M | -$853000 | -$296000 | -$294000 | -$6.9M | $85000 |
| Flujo de Caja Operativo | $8.4M | $7.9M | $8.1M | $8.0M | $9.7M | $6.3M | $7.2M | $5.7M | $167000 | $3.1M |
| Inversiones (CapEx) | -$1.6M | -$803000 | -$1.6M | -$990000 | -$455000 | -$1.7M | -$388000 | -$6.3M | -$7.9M | -$7.6M |
| Adquisiciones | $7000 | $150000 | 0 | 0 | -$2.1M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $6.8M | $7.0M | $6.5M | $7.1M | $9.3M | $4.6M | $6.8M | -$555000 | -$7.8M | -$4.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $1.7M | -$704000 | $2.1M | $2.2M |
| Inversiones (CapEx) | -$3.7M | $2.0M | -$41000 | -$58000 |
| Flujo de Caja Libre | -$2.0M | $1.3M | $2.1M | $2.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $403.7M | 0 | $102000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +4.6% | +0.8% | +4.5% | -13.4% | -1.2% | +12.0% | +8.0% | +32.9% | -0.9% |
| Crecimiento Beneficio Neto (anual) | | +106.8% | -46.8% | -35.6% | -1171.0% | +102.7% | +584.5% | -54.1% | +258.4% | -171.0% |
| Crecimiento BPA (anual) | | +94.1% | -45.5% | +33.3% | -575.0% | +102.8% | +554.2% | -54.3% | +254.5% | -167.6% |
| Cambio en Acciones (anual) | | +6.5% | +3.3% | -1.5% | +4.2% | -2.0% | +4.0% | +1.4% | +4.8% | -1.3% |
| Crecimiento FCF (anual) | | +4.2% | -8.0% | +8.8% | +31.6% | -50.6% | +49.1% | -108.1% | -1300.2% | +41.6% |
| Margen Bruto | 47.0% | 44.3% | 38.0% | 33.6% | 25.0% | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| Margen Operativo | 17.6% | 12.3% | 9.4% | -22.0% | -53.1% | 7.7% | 12.3% | 1.3% | -9.9% | -7.2% |
| Margen EBITDA | 60.5% | 56.3% | 52.3% | 49.8% | -8.0% | 39.5% | 42.8% | 32.7% | 31.4% | 14.5% |
| Margen Neto | 5.0% | 9.8% | 5.2% | 3.2% | -39.6% | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% |
| Margen FCF | 36.2% | 36.1% | 32.9% | 34.2% | 52.1% | 26.1% | 34.7% | -2.6% | -27.4% | -16.2% |
| Tasa Impositiva Efectiva | 29.5% | -60.0% | 21.7% | 8.2% | 18.4% | 28.4% | 38.2% | 61.9% | -23.8% | 15.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $1.24 | $1.21 | $1.08 | $1.19 | $1.50 | $0.76 | $1.09 | $-0.09 | $-1.16 | $-0.69 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $5.5M | $5.8M | $5.8M | $5.9M | $6.2M | $6.0M | $6.3M | $6.4M | $6.5M | $6.6M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -7.45% |
| Rentabilidad sobre capital invertido | -5.52% |
| Rentabilidad sobre activos | -3.38% |
| Margen bruto | 17.10% |
| Margen operativo | -8.43% |
| Margen neto | -5.83% |
Salud financiera
| Deuda / Patrimonio | 0.89 |
| Ratio corriente | 0.77 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.67 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | 19.71 | 7.87 | 13.22 | 10.17 | -1.95 | 73.83 | 13.95 | 24.82 | 9.38 | -9.17 |
| P/VC | 0.67 | 0.50 | 0.45 | 0.45 | 0.71 | 0.72 | 0.85 | 0.67 | 0.82 | 0.58 |
| P/V | 0.98 | 0.76 | 0.70 | 0.70 | 0.77 | 0.81 | 0.93 | 0.71 | 0.73 | 0.50 |
| Margen Bruto | 47.0% | 44.3% | 38.0% | 33.6% | 25.0% | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| Margen Operativo | 17.6% | 12.3% | 9.4% | -22.0% | -53.1% | 7.7% | 12.3% | 1.3% | -9.9% | -7.2% |
| Margen Neto | 5.0% | 9.8% | 5.2% | 3.2% | -39.6% | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% |